BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16038189)

  • 21. An UPLC-MS/MS method for separation and accurate quantification of tamoxifen and its metabolites isomers.
    Arellano C; Allal B; Goubaa A; Roché H; Chatelut E
    J Pharm Biomed Anal; 2014 Nov; 100():254-261. PubMed ID: 25173109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of 4-hydroxytamoxifen in mouse plasma in the pg/mL range by gradient capillary liquid chromatography/tandem mass spectrometry.
    Plumb RS; Warwick H; Higton D; Dear GJ; Mallett DN
    Rapid Commun Mass Spectrom; 2001; 15(4):297-303. PubMed ID: 11223962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitive HPLC-PDA determination of tamoxifen and its metabolites N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in human plasma.
    Antunes MV; Rosa DD; Viana Tdos S; Andreolla H; Fontanive TO; Linden R
    J Pharm Biomed Anal; 2013 Mar; 76():13-20. PubMed ID: 23291438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct determination of tamoxifen and its four major metabolites in plasma using coupled column high-performance liquid chromatography.
    Fried KM; Wainer IW
    J Chromatogr B Biomed Appl; 1994 May; 655(2):261-8. PubMed ID: 8081472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of phase I and phase II metabolites of tamoxifen in breast cancer patients.
    Poon GK; Chui YC; McCague R; Lłnning PE; Feng R; Rowlands MG; Jarman M
    Drug Metab Dispos; 1993; 21(6):1119-24. PubMed ID: 7905393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extraction of tamoxifen and its metabolites from formalin-fixed, paraffin-embedded tissues: an innovative quantitation method using liquid chromatography and tandem mass spectrometry.
    Ng ES; Kangarloo SB; Konno M; Paterson A; Magliocco AM
    Cancer Chemother Pharmacol; 2014 Mar; 73(3):475-84. PubMed ID: 24414550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative measurement of 4-hydroxy tamoxifen in human plasma and mammary tumours by combined gas chromatography/negative chemical ionization mass spectrometry.
    Girault J; Istin B; Fourtillan JB
    Biol Mass Spectrom; 1993 Jul; 22(7):395-402. PubMed ID: 8357855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reductive amination-assisted quantitation of tamoxifen and its metabolites by liquid phase chromatography tandem mass spectrometry.
    Liang SS; Wang TN; Chiu CC; Kuo PL; Huang MF; Liu MC; Tsai EM
    J Chromatogr A; 2016 Feb; 1434():64-9. PubMed ID: 26814364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of tamoxifen and metabolites by LC-MS/MS and HPLC methods.
    Heath DD; Flat SW; Wu AH; Pruitt MA; Rock CL
    Br J Biomed Sci; 2014; 71(1):33-9. PubMed ID: 24693573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural elucidation of new urinary tamoxifen metabolites by liquid chromatography quadrupole time-of-flight mass spectrometry.
    Lu J; He C; He G; Wang X; Xu Y; Wu Y; Dong Y; Ouyang G
    J Mass Spectrom; 2014 Jul; 49(7):570-8. PubMed ID: 25044841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of M+4 stable isotope labeled cortisone and cortisol in human plasma by microElution solid-phase extraction and liquid chromatography/tandem mass spectrometry.
    Yang AY; Sun L; Musson DG; Zhao JJ
    Rapid Commun Mass Spectrom; 2006; 20(2):233-40. PubMed ID: 16345110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Automated in-tube solid-phase microextraction coupled with liquid chromatography/electrospray ionization mass spectrometry for the determination of beta-blockers and metabolites in urine and serum samples.
    Kataoka H; Narimatsu S; Lord HL; Pawliszyn J
    Anal Chem; 1999 Oct; 71(19):4237-44. PubMed ID: 10517146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing high-performance liquid chromatography method with fluorescence detection for quantification of tamoxifen and two metabolites in human plasma: application to a clinical study.
    Zhu YB; Zhang Q; Zou JJ; Yu CX; Xiao DW
    J Pharm Biomed Anal; 2008 Jan; 46(2):349-55. PubMed ID: 18037598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly sensitive simultaneous quantification of estrogenic tamoxifen metabolites and steroid hormones by LC-MS/MS.
    Johänning J; Heinkele G; Precht JC; Brauch H; Eichelbaum M; Schwab M; Schroth W; Mürdter TE
    Anal Bioanal Chem; 2015 Sep; 407(24):7497-502. PubMed ID: 26206706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study.
    Beer B; Schubert B; Oberguggenberger A; Meraner V; Hubalek M; Oberacher H
    Anal Bioanal Chem; 2010 Oct; 398(4):1791-800. PubMed ID: 20730580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of tamoxifen and its metabolites in human plasma by gas chromatography-mass spectrometry (GC-MS) using selected ion monitoring (SIM).
    Murphy C; Fotsis T; Pantzar P; Adlercreutz H; Martin F
    J Steroid Biochem; 1987 May; 26(5):547-55. PubMed ID: 3586671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of highly selective LC-MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen.
    Jager NG; Rosing H; Linn SC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2012 Jun; 133(2):793-8. PubMed ID: 22388692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solid-phase extraction and high-performance liquid chromatographic determination of tamoxifen and its major metabolites in breast tumour tissues.
    MacCallum J; Cummings J; Dixon JM; Miller WR
    J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):269-75. PubMed ID: 9367217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tamoxifen metabolite isomer separation and quantification by liquid chromatography-tandem mass spectrometry.
    Jaremko M; Kasai Y; Barginear MF; Raptis G; Desnick RJ; Yu C
    Anal Chem; 2010 Dec; 82(24):10186-93. PubMed ID: 21086978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a methodology to quantify tamoxifen and endoxifen in breast cancer patients by micellar liquid chromatography and validation according to the ICH guidelines.
    Aranda EO; Esteve-Romero J; Rambla-Alegre M; Peris-Vicente J; Bose D
    Talanta; 2011 Apr; 84(2):314-8. PubMed ID: 21376950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.